(Q44428408)

2 December 2017

Angiotensin-converting enzyme 2 activity in patients with chronic kidney disease (English)

1 reference

2 December 2017

Matthew A Roberts

1

1 reference

2 December 2017

Elena Velkoska

series ordinal

2

1 reference

2 December 2017

Francesco L Ierino

series ordinal

3

1 reference

2 December 2017

Louise M Burrell

series ordinal

4

1 reference

2 December 2017

language of work or name

English

0 references

publication date

27 March 2013

1 reference

Nephrology Dialysis Transplantation

2 December 2017

1 reference

2 December 2017

28

1 reference

2 December 2017

9

1 reference

2 December 2017

2287-2294

1 reference

Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population

2 December 2017

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

The importance of the intrarenal renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Myocardial infarction increases ACE2 expression in rat and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

ACE2, a new regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Angiotensin-converting enzyme 2 is an essential regulator of heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Serial increased cardiac troponin T predicts mortality in asymptomatic patients treated with chronic haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Cardiac troponin levels in asymptomatic patients on the renal transplant waiting list

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

B-type natriuretic peptides strongly predict mortality in patients who are treated with long-term dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

MDRD equations for estimation of GFR in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Angiotensin-(1-7) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFT038

Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23535224

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NDT/GFT038

1 reference

2 December 2017

1 reference